Eli Lilly & Co. vs Medtronic plc
LLY vs MDT — side-by-side comparison from reported financials. LLY leads 7, MDT leads 3 of 10 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Medtronic plc
MDT · Healthcare
$88.01+0.30%Mixed
| Metric | LLY | MDT |
|---|---|---|
| Price | $1 177.20 | $88.01 |
| Market cap | $1.05T | $113B |
| Revenue (TTM) | $79.7B | $37.5B |
| Revenue growth | +31.7% | +5.2% |
| Net margin | 33.5% | 13.9% |
| Free cash flow | $18.2B | $6.13B |
| Net cash (debt) | ($35.2B) | — |
| 1-year price return | +37.6% | -8.8% |
| P/E | 41.6 | 21.6 |
| P/E vs own history (cheap-side %) | 88% | 96% |
| Dividend yield | 0.52% | 3.22% |
| Return on equity | 93% | 11% |
| Altman Z-score | 7.10 | — |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 50,000 | 95,000 |
Full résumé-style profiles: LLY CV · MDT CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.